China SXT Pharmaceuticals (SXTC) Operating Leases (2023 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Operating Leases of $53442.0 for Q1 2026, down 53.7% year-over-year from $115419.0 in Q1 2025, and down 37.25% quarter-over-quarter from $85161.0 in Q3 2025.
China SXT Pharmaceuticals (SXTC) Operating Leases (2023 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Operating Leases history runs 4 years deep, the most recent figure standing at $53442.0 for Q1 2026.
- In Q1 2026, Operating Leases fell 53.7% year-over-year to $53442.0; the TTM figure through Mar 2026 stood at $53442.0 (down 53.7% YoY), while the FY2026 annual figure was $53442.0, down 53.7% from the prior year.
- Operating Leases for Q1 2026 stood at $53442.0, down from $85161.0 in the prior quarter.
- The five-year high for Operating Leases was $306050.0 in Q1 2023, with the low at $53442.0 in Q1 2026.
- The 4-year median for Operating Leases is $149278.0 (2024), against an average of $164305.0.
- The sharpest annual moves came in 2024 and 2026: Operating Leases slipped 22.94% in 2024, then sank 53.7% in 2026.
- China SXT Pharmaceuticals' Operating Leases stood at $204937.0 in 2023, then declined by 27.16% to $149278.0 in 2024, then tumbled by 42.95% to $85161.0 in 2025, then slumped by 37.25% to $53442.0 in 2026.
- Business Quant data shows SXTC's Operating Leases at $53442.0 in Q1 2026, $85161.0 in Q3 2025, and $115419.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | China SXT Pharmaceuticals | 32,922.00 | -28.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53,442.00 |
| Sep 30, 2025 | 85,161.00 |
| Mar 31, 2025 | 115,419.00 |
| Sep 30, 2024 | 149,278.00 |
| Mar 31, 2024 | 235,848.00 |
| Sep 30, 2023 | 204,937.00 |
| Mar 31, 2023 | 306,050.00 |